CN110767270A - Virtual drug test system - Google Patents
Virtual drug test system Download PDFInfo
- Publication number
- CN110767270A CN110767270A CN201911057793.XA CN201911057793A CN110767270A CN 110767270 A CN110767270 A CN 110767270A CN 201911057793 A CN201911057793 A CN 201911057793A CN 110767270 A CN110767270 A CN 110767270A
- Authority
- CN
- China
- Prior art keywords
- reaction
- drug
- library
- medicines
- virtual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000006243 chemical reaction Methods 0.000 claims abstract description 127
- 239000003814 drug Substances 0.000 claims abstract description 124
- 229940079593 drug Drugs 0.000 claims abstract description 99
- 230000007246 mechanism Effects 0.000 claims abstract description 40
- 238000006757 chemical reactions by type Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 23
- 230000008569 process Effects 0.000 claims description 21
- 230000002159 abnormal effect Effects 0.000 claims description 8
- 206010067484 Adverse reaction Diseases 0.000 claims description 7
- 230000006838 adverse reaction Effects 0.000 claims description 7
- 230000035484 reaction time Effects 0.000 claims description 3
- 238000009423 ventilation Methods 0.000 claims description 3
- 238000012360 testing method Methods 0.000 abstract description 23
- 238000003255 drug test Methods 0.000 abstract description 16
- 239000000463 material Substances 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/10—Analysis or design of chemical reactions, syntheses or processes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/90—Programming languages; Computing architectures; Database systems; Data warehousing
Abstract
The invention discloses a virtual drug test system, which comprises the following steps: inputting the selected reaction medicine on a computer input interface; searching related medicine characteristics in a medicine characteristic library according to the input medicines, and transmitting related data to a reaction mechanism library; the reaction mechanism library distinguishes the reaction types according to the corresponding drug characteristics and the reaction mechanisms among the drugs; after the normal reaction is determined, a condition control library is called to constrain each condition in the drug reaction process; the reaction between the medicines is normally carried out through the reaction system, and the reaction result is fed back on the computer display interface. The virtual drug test system stores a large number of drug characteristics and related reaction mechanisms by establishing the drug characteristic library and the reaction mechanism library, thereby ensuring the normal operation of drug tests, reducing the workload of workers for independently searching and inputting the drug characteristics and improving the overall test efficiency of the system.
Description
Technical Field
The invention relates to the technical field of drug tests, in particular to a virtual drug test system.
Background
In life, people are ill unexpectedly due to various reasons, aiming at sudden physical conditions, the traditional Chinese medicine solution can be selected, the western medicine solution can be selected, but the doctor finally goes into the medication link no matter in the traditional Chinese medicine or the western medicine, in recent years, various novel flu is abused, various laboratories can research related treatment medicines aiming at illness states, all the treatment medicines cannot be prepared from single medicinal materials, a large number of complex pharmacological test processes are doped, a large number of medicinal materials and labor are consumed in the new medicine development process, finally, the medicine development failure can be caused by one detail in the process, the traditional laboratories have large limitation on new medicines, unbalanced test resources, insufficient test expenditure, insufficient labor and the like are all short boards of the traditional laboratories, along with the development of scientific and technological progress and internet virtual technology, the existing virtual test system can break the limitation of most traditional laboratories, and the virtual drug test system has the following characteristics:
1. the drug test is no longer limited to regions, environments and laboratory conditions, and the virtual test enables researchers to carry out test operation through the network terminal at any time and place;
2. the virtual drug test solves the problems of expensive test instrument equipment and test materials, ensures the advancement of the test instrument and the sufficiency of test expenses, and solves the safety problem in the drug reaction process.
Therefore, the virtual drug test system with simple operation process, good test effect and high safety coefficient is provided.
Disclosure of Invention
The present invention is directed to a virtual drug testing system to solve the above problems.
In order to achieve the purpose, the invention provides the following technical scheme: a virtual drug testing system comprising the steps of:
inputting the selected reaction medicine on a computer input interface;
searching related medicine characteristics in a medicine characteristic library according to the input medicines, and transmitting related data to a reaction mechanism library;
the reaction mechanism library distinguishes the reaction types according to the corresponding drug characteristics and the reaction mechanisms among the drugs;
after the normal reaction is determined, a condition control library is called to constrain each condition in the drug reaction process;
the reaction between the medicines is normally carried out through the reaction system, and the reaction result is fed back on the computer display interface.
Preferably, the drug property library has previously recorded therein the properties of the desired reaction drugs, and the reaction mechanism library has previously recorded therein the reaction mechanisms between the desired reaction drugs.
Preferably, the reaction between the drugs in the reaction mechanism library is specifically divided into adverse reactions, normal reactions and contraindication reactions, the system optimizes the adverse reactions and then carries out the reactions between the drugs, and the contraindication reactions directly trigger the alarm system.
Preferably, the condition control library includes, but is not limited to, temperature, ph of reaction environment, drug dosage, drug addition time node, state of drug addition, drug addition sequence, drug reaction time, ventilation condition, and light, and the condition control library may make reaction conditions different between some drugs.
Preferably, the reaction system will remember the mechanism of normal and abnormal reactions and the control conditions in the associated process.
Preferably, the abnormal reaction triggers an alarm system, and the characteristics and mutual reaction mechanism of the medicines are searched again, so that the target reaction result between the medicines is achieved by changing the control condition of the reaction.
Compared with the prior art, the invention has the beneficial effects that:
1. the drug property library and the reaction mechanism library are established to store a large number of drug properties and related reaction mechanisms, so that the normal operation of a drug test is ensured, the workload of a worker for independently searching and inputting the drug properties is reduced, and the overall test efficiency of the system is improved;
2. the established condition control library is convenient for a tester to control the reaction conditions according to the actual reaction conditions of the relevant reactions, so that the control flow of the reaction conditions is more flexible, the control conditions can be changed after all the drugs are added, and a part of the reaction conditions can be changed or a part of the drugs can be added after part of the drugs react under certain conditions, so that the whole process of the drug tests is more diversified, and the normal operation of various drug tests is ensured;
3. the establishment of the whole virtual drug test system realizes instrument equipment and related test materials in a virtual state, solves the problem of influence on drug test process caused by reasons such as expense shortage, improper equipment operation, poor laboratory management and the like, simultaneously enables the drug test flow to be more diversified, improves the innovativeness, increases the research success rate of novel drugs, and avoids safety problems generated in the drug test process in the virtual drug test.
Drawings
Fig. 1 is an overall work flow diagram of the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Referring to fig. 1, the present invention provides a technical solution: a virtual drug testing system comprising the steps of:
inputting the selected reaction medicine on a computer input interface;
in the embodiment of the invention, a medicine input interface, a reaction result display interface, an alarm interface and an operation interface are mutually combined on a display screen of a computer.
Searching related medicine characteristics in a medicine characteristic library according to the input medicines, and transmitting related data to a reaction mechanism library;
in the embodiment of the invention, the range of the drugs recorded in the drug property library is wide, the establishment of the drug property library in advance is beneficial to the storage of respective properties of related drugs, the property retrieval of the drugs in the test process is convenient, the delay time is reduced, and the drug property library is updated in time to ensure the accuracy and the safety of the drug test.
The reaction mechanism library distinguishes the reaction types according to the corresponding drug characteristics and the reaction mechanisms among the drugs;
in the embodiment of the invention, the reaction mechanism library stores various pharmacological reactions, drug combination reactions and physical reactions, and stores failure reactions and successful reaction mechanisms in the operation process of the virtual drug test system, so that experience guarantee is provided for the subsequent drug reactions, the reaction mechanism library established in advance stores the known drug reaction mechanisms, abnormal reactions of drugs in the test process are avoided, and the operation amount in the drug test process is reduced.
After the normal reaction is determined, a condition control library is called to constrain each condition in the drug reaction process;
in the embodiment of the invention, the operation process of the condition control library is flexible, the control condition can be changed after all the medicines are added, and a part of reaction conditions can be changed or a part of medicines can be added after a part of medicines react under a certain condition, so that the whole process of the medicine test is more diversified, and the normal operation of various medicine tests is ensured.
The reaction between the medicines is normally carried out through the reaction system, and the reaction result is fed back on the computer display interface.
In the invention: the drug property library has previously recorded the properties of the required reaction drugs, and the reaction mechanism library has previously recorded the reaction mechanisms among the required reaction drugs. In the embodiment, the medicament characteristic library and the reaction mechanism library which are established in advance store a large number of medicament characteristics and relevant reaction mechanisms, so that the normal operation of a medicament test is ensured, the workload of a worker for independently searching and inputting the medicament characteristics is reduced, and the overall test efficiency of the system is improved.
In the invention: the reaction mechanism library is used for specifically dividing the reaction between the medicines into adverse reaction, normal reaction and contraindication reaction, the system can optimize the adverse reaction and then carry out the reaction between the medicines, and the contraindication reaction directly triggers the alarm system. In the embodiment, the contraindication reaction is that the system determines that one or more drugs can generate drugs outside a test in the same reaction after searching the drug characteristic library and the reaction mechanism library according to the input drugs, so that the treatment effect of the drugs on symptoms is influenced or the health of a human body is directly influenced, the adverse reaction means that the reaction between the input drugs lacks other intermediate drugs or the reaction generates a reaction which slightly influences the drug characteristics, the optimization re-reaction can be performed according to an optimization scheme, and the safety in the test process of the virtual drug test system is ensured.
In the invention: the condition control library includes, but is not limited to, temperature, pH of reaction environment, drug dosage, drug addition time node, state of drug addition, drug addition sequence, drug reaction time, ventilation condition, and light, and the condition control library may make reaction conditions different between some drugs. In the embodiment, the reaction results of the drugs generated under different reaction conditions are different, and the control of various control conditions makes the test process of the drugs more convenient and efficient.
In the invention: the reaction system will remember the mechanism of normal and abnormal reactions and the control conditions in the relevant processes. In the embodiment, reaction mechanisms generated in the drug test system are memorized in the system, so that experience supplementation is provided for drug tests, the subsequent drug tests are convenient to carry out, the similar failure condition of similar drug tests is avoided, and the efficiency of the drug tests of the system is effectively improved.
In the invention: the abnormal reaction triggers an alarm system, the characteristics and mutual reaction mechanism of the medicines are searched again, and the target reaction result between the medicines is achieved by changing the control condition of the reaction. In the embodiment, the mechanism of the abnormal reaction triggering alarm system effectively controls the safety of the reaction between the medicines, avoids the situation that the medicines generate harmful substances in the test process or the medicines generated by the reaction have adverse effects on diseases, and ensures the safety of the test result.
It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
The above description is only a preferred embodiment of the present invention, and is not intended to limit the scope of the present invention, and all modifications and equivalents of the present invention, which are made by the contents of the present specification and the accompanying drawings, or directly/indirectly applied to other related technical fields, are included in the scope of the present invention.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (6)
1. A virtual drug testing system, comprising the steps of:
inputting the selected reaction medicine on a computer input interface;
searching related medicine characteristics in a medicine characteristic library according to the input medicines, and transmitting related data to a reaction mechanism library;
the reaction mechanism library distinguishes the reaction types according to the corresponding drug characteristics and the reaction mechanisms among the drugs;
after the normal reaction is determined, a condition control library is called to constrain each condition in the drug reaction process;
the reaction between the medicines is normally carried out through the reaction system, and the reaction result is fed back on the computer display interface.
2. The virtual drug testing system of claim 1, wherein: the drug property library has previously recorded the properties of the required reaction drugs, and the reaction mechanism library has previously recorded the reaction mechanisms among the required reaction drugs.
3. The virtual drug testing system of claim 1, wherein: the reaction mechanism library is used for specifically dividing the reaction between the medicines into adverse reaction, normal reaction and contraindication reaction, the system can optimize the adverse reaction and then carry out the reaction between the medicines, and the contraindication reaction directly triggers the alarm system.
4. The virtual drug testing system of claim 1, wherein: the condition control library includes, but is not limited to, temperature, pH of reaction environment, drug dosage, drug addition time node, state of drug addition, drug addition sequence, drug reaction time, ventilation condition, and light, and the condition control library may make reaction conditions different between some drugs.
5. The virtual drug testing system of claim 1, wherein: the reaction system will remember the mechanism of normal and abnormal reactions and the control conditions in the relevant processes.
6. The virtual drug testing system of claim 1, wherein: the abnormal reaction triggers an alarm system, the characteristics and mutual reaction mechanism of the medicines are searched again, and the target reaction result between the medicines is achieved by changing the control condition of the reaction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911057793.XA CN110767270A (en) | 2019-11-01 | 2019-11-01 | Virtual drug test system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911057793.XA CN110767270A (en) | 2019-11-01 | 2019-11-01 | Virtual drug test system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110767270A true CN110767270A (en) | 2020-02-07 |
Family
ID=69335173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911057793.XA Pending CN110767270A (en) | 2019-11-01 | 2019-11-01 | Virtual drug test system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110767270A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102968567A (en) * | 2012-11-30 | 2013-03-13 | 西安福安创意咨询有限责任公司 | Decision support mechanism for clinical safe and rational drug use |
| CN106455996A (en) * | 2014-03-31 | 2017-02-22 | 皇家飞利浦有限公司 | Method and device for the non-invasive monitoring and identification of drug effects and interactions |
| CN108984811A (en) * | 2017-06-05 | 2018-12-11 | 欧阳德方 | A kind of pharmaceutical preparation prescription virtual design and the method and system of assessment |
| CN109065101A (en) * | 2018-06-20 | 2018-12-21 | 广州中国科学院软件应用技术研究所 | Clinical drug trial monitoring method, system, equipment and medium based on block chain |
| CN109767817A (en) * | 2019-01-16 | 2019-05-17 | 南通大学 | A kind of drug potential adverse effect discovery method based on neural network language model |
-
2019
- 2019-11-01 CN CN201911057793.XA patent/CN110767270A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102968567A (en) * | 2012-11-30 | 2013-03-13 | 西安福安创意咨询有限责任公司 | Decision support mechanism for clinical safe and rational drug use |
| CN106455996A (en) * | 2014-03-31 | 2017-02-22 | 皇家飞利浦有限公司 | Method and device for the non-invasive monitoring and identification of drug effects and interactions |
| CN108984811A (en) * | 2017-06-05 | 2018-12-11 | 欧阳德方 | A kind of pharmaceutical preparation prescription virtual design and the method and system of assessment |
| CN109065101A (en) * | 2018-06-20 | 2018-12-21 | 广州中国科学院软件应用技术研究所 | Clinical drug trial monitoring method, system, equipment and medium based on block chain |
| CN109767817A (en) * | 2019-01-16 | 2019-05-17 | 南通大学 | A kind of drug potential adverse effect discovery method based on neural network language model |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chisholm et al. | Niche and neutral models predict asymptotically equivalent species abundance distributions in high-diversity ecological communities | |
| Dunaif | Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome? | |
| Demenkov et al. | ANDVisio: a new tool for graphic visualization and analysis of literature mined associative gene networks in the ANDSystem | |
| CN108648810B (en) | Data processing method and device for medical audit and computer readable storage medium | |
| Baker 3rd et al. | Learning style analysis in surgical training. | |
| CN108537008A (en) | High-throughput gene sequencing big data analysis cloud platform system | |
| Mazanec et al. | Drug-induced osteoporosis. | |
| Her et al. | A query workflow design to perform automatable distributed regression analysis in large distributed data networks | |
| US11631482B2 (en) | Visualising clinical and genetic data | |
| CN110767270A (en) | Virtual drug test system | |
| US9201960B2 (en) | Virtual agent response to customer inquiries | |
| CN112069190B (en) | Batch data acquisition method, device, equipment and medium | |
| Zhang | Extracting functional information from microarrays: a challenge for functional genomics | |
| Craghead et al. | An evaluative study of unclaimed prescriptions. | |
| Ghosh et al. | Joint modeling of longitudinal data and informative dropout time in the presence of multiple changepoints | |
| CN110020345A (en) | Financial Information exchange method and device based on ranking | |
| CN113707262A (en) | Medicine use recommendation method and device, computer equipment and storage medium | |
| Hallfeldt et al. | Laparoscopic adhesiolysis in therapy of chronic abdominal pain | |
| Reaby | The effectiveness of an education program to teach Australian nurses comprehensive physical assessment skills. | |
| Linnarsson et al. | A shared computer-based problem-oriented patient record for the primary care team. | |
| Cheson | Cancer clinical trials. Clinical trials programs. | |
| CN116110607B (en) | Method and system for checking detection data of traditional Chinese medicine components | |
| Yang et al. | Integrating herb effect similarity for network-based herb target prediction | |
| Blum et al. | A clinical information display system | |
| CN113921089B (en) | Method and system for confirming updating frequency of IVD gene annotation database |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200207 |
|
| WD01 | Invention patent application deemed withdrawn after publication |